FDA
-
-
-
-
-
-
-
GeneDx to Participate in Upcoming Investor Conferences
-
-
-
-
-
-
-
GeneDx to Report First Quarter 2026 Financial Results on Monday, May 4, 2026
-
-
-
-
-
-
-
GeneDx posts 41% revenue growth, issues 2026 guidance
-
-
-
-
-
-
-
GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care
-
-
-
-
-
-
334,273 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


